White Paper

Proven Benefits of Gene Expression Profiling for Biomarker Discovery in Immunotherapy Trials

Gene Expression for Keeping Pace with Immuno-oncology Breakthroughs and Biomarker Identification

The development of recent immunotherapies has resulted in significantly improved outcomes for some patients suffering from serious cancers. Genomics, in addition to advanced technology, can empower the success of these therapies and reveal new insights to keep pace with today’s rapid advance in therapeutic breakthroughs.

In this whitepaper, you’ll learn about the clinical relevance of advanced technologies, such as RNA-Sequencing, and when and how to use gene expression profiling for biomarker discovery for immunotherapy trials.

Contact us to learn how we can advance your immuno-oncology drug development program.

Contact Q2 Solutions
Talk To an Expert Contact Our Offices

More Resources

Fighting Cancer: How Biomarker Testing and 3 Key Research Tools Shape Immunotherapy Drug Development
6 Key Elements of Successful Companion Diagnostic Development
Learn 3 Ways to Optimize Your Companion Diagnostic Strategy
View All